CVE-2026-101549

Awaiting Analysis Awaiting Analysis - Queue

Privilege Escalation in Oracle Application Testing Suite

Publication date: 2026-10-20

Last updated on: 2026-11-08

Assigner: Oracle

Description

Vulnerability in Oracle Application Testing Suite (component: OpenScript). The supported version that is affected is 13.3.0.1. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle Application Testing Suite executes to compromise Oracle Application Testing Suite. Successful attacks of this vulnerability can result in takeover of Oracle Application Testing Suite. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published

2026-10-20

Last Modified

2026-11-08

Generated

2026-11-10

AI Q&A

2026-10-21

EPSS Evaluated

2026-11-08

NVD

CVE-2026-101549

EUVD

EUVD-2026-105960

Affected Vendors & Products

Vendor	Product	Version / Range
Oracle Corporation	Oracle Application Testing Suite	13.3.0.1

Helpful Resources

Exploitability

CWE

KEV

CWE ID	Description
CWE-269	The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.

Attack-Flow Graph

Executive Summary

This is a vulnerability in Oracle Application Testing Suite version 13.3.0.1. It allows a low-privileged attacker with local access to compromise the suite and potentially take it over. The attack requires logon to the system where the suite runs.

Detection Guidance

Detection of this vulnerability requires checking for the presence of Oracle Application Testing Suite version 13.3.0.1 on your system. Review installed software versions and compare them against the affected version. No specific commands are provided in the context to directly detect exploitation.

Impact Analysis

If exploited, an attacker could gain full control over Oracle Application Testing Suite, leading to unauthorized access, data breaches, or disruption of testing operations. This could affect confidentiality, integrity, and availability of the system.

Compliance Impact

This vulnerability allows low-privileged attackers to compromise Oracle Application Testing Suite, potentially leading to unauthorized access and control. Such breaches could result in exposure of sensitive data, which may violate compliance requirements under GDPR (data protection) and HIPAA (health information privacy).

Mitigation Strategies

Apply the latest security patches or updates provided by Oracle for Oracle Application Testing Suite version 13.3.0.1 to address the vulnerability.

Hi! I’m here to help you understand CVE-2026-101549. Ask me anything about the vulnerability, its impact, or mitigation strategies.

0/70

EPSS Chart

Security Radar

News mentioning this vulnerability

Loading related security news...